QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML

NCT03365661 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor halted study.

Conditions

High-Risk Acute Myeloid Leukemia
Treatment-Related Acute Myeloid Leukemia
Secondary Acute Myeloid Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: ALT-803

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]